Uwe Schoenbeck
Direktor/Vorstandsmitglied bei Alterome Therapeutics, Inc.
Aktive Positionen von Uwe Schoenbeck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Private Equity Investor | - | - |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Uwe Schoenbeck
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Health Technology |
- Börse
- Insiders
- Uwe Schoenbeck
- Erfahrung
